Form 4: CalciMedica Chief Business Officer Boosts Stake with Significant Stock Purchases

Eric W. Roberts, CalciMedica's Chief Business Officer, Director, and 10% Owner, reported recent purchases of common stock totaling 10,100 shares, signaling increased insider confidence.

Summary

• Eric W. Roberts, who serves as Chief Business Officer, Director, and a 10% Owner of CalciMedica, Inc. (CALC), reported two separate purchases of the company's common stock.
• On June 5, 2025, Mr. Roberts acquired 5,100 shares of common stock at a weighted average price of $1.70 per share, with the transaction prices ranging from $1.6638 to $1.7274.
• On June 6, 2025, an additional 5,000 shares of common stock were purchased at a weighted average price of $1.775 per share, with prices ranging from $1.75 to $1.87.
• Both transactions were executed indirectly through an FMTC Custodian Roth IRA FBO Eric W. Roberts.
• Following these purchases, Mr. Roberts' indirect beneficial ownership through this specific Roth IRA increased to 23,323 shares.
• His total beneficial ownership across all direct and indirect holdings, including other Roth IRAs and various Valence Investments SPVs, amounts to 985,910 shares of CalciMedica Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is positive due to significant insider buying by a high-ranking executive and major shareholder, indicating strong confidence in the company's future.

Positives

• The purchases by Eric W. Roberts, a key executive (Chief Business Officer) and significant shareholder (10% owner), indicate strong insider confidence in CalciMedica's future prospects and valuation.
• The acquisition of shares at market prices suggests that management believes the stock is currently undervalued or has substantial upside potential.

Risks

• While insider buying is generally a positive signal, it does not guarantee future stock performance or insulate the company from broader market or industry risks.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's financial performance or strategic outlook.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends. However, insider buying can be a signal of confidence within the specific industry sector.

Related Party Transactions

• The reported purchases of common stock by Eric W. Roberts, who holds roles as Chief Business Officer, Director, and a 10% owner of CalciMedica, Inc., constitute related party transactions as they involve an insider acquiring securities of the company.

Stakeholder Impact

• Shareholders may view these insider purchases as a positive indicator, potentially boosting investor confidence and influencing market perception of the company's stock.

Key Dates

Keywords

CalciMedica, CALC, insider trading, Form 4, stock purchase, beneficial ownership, Eric W. Roberts, Chief Business Officer, Director, 10% Owner